• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,532.96 325.72
( 0.44%)
Global Indices
Nasdaq
45,612.20 -430.24
(-0.93%)
Dow Jones
6,526.68 -100.81
(-1.52%)
Hang Seng
53,297.18 -1,942.22
(-3.52%)
Nikkei 225
9,927.54 -135.96
(-1.35%)
Forex
USD-INR
93.13 0.41
(0.44%)
EUR-INR
107.17 0.41
(0.39%)
GBP-INR
124.14 0.56
(0.45%)
JPY-INR
0.59 0.00
(0.73%)

EQUITY - MARKET SCREENER

Presstonic Engineering Ltd
Industry :  Engineering
BSE Code
ISIN Demat
Book Value()
92232
INE0R1601012
34.1615937
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PRESSTONIC
61.25
52.87
EPS(TTM)
Face Value()
Div & Yield %
0.56
10
0
 

Board of Sanofi India approves change in directorate
Oct 27,2025
The Board of Sanofi India at its meeting held on 27 October 2025 has approved the following-

Appointment of Deepak Arora (DIN: 07495638) as an Additional Director of the Company with effect from 27 October 2025 and as a Managing Director (Key Managerial Personnel) of the Company for a term of 3 (three) years effective from 27 October 2025.

Stepping down of Rachid Ayari as Interim Managing Director of the Company with effect from close of 26 October 2025. However, Rachid Ayari would continue to serve the Company in his role as Whole time Director and Chief Financial Officer of the Company.